Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
US Army
US Department of Justice
McKinsey
Moodys
Healthtrust
Teva
Deloitte
Cantor Fitzgerald

Generated: June 25, 2018

DrugPatentWatch Database Preview

Alpharma Us Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for ALPHARMA US PHARMS, and what generic and branded alternatives to ALPHARMA US PHARMS drugs are available?

ALPHARMA US PHARMS has sixty-one approved drugs.



Summary for Alpharma Us Pharms
US Patents:0
Tradenames:43
Ingredients:40
NDAs:61

Drugs and US Patents for Alpharma Us Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alpharma Us Pharms TRIMEPRAZINE TARTRATE trimeprazine tartrate SYRUP;ORAL 085015-001 Feb 18, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Alpharma Us Pharms TRIMETH/SULFA sulfamethoxazole; trimethoprim SUSPENSION;ORAL 072398-001 May 23, 1988 DISCN No No ➤ Sign Up ➤ Sign Up
Alpharma Us Pharms TRIPLE SULFA triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole) CREAM;VAGINAL 087864-001 Sep 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Alpharma Us Pharms ERYTHROMYCIN ESTOLATE erythromycin estolate SUSPENSION;ORAL 062353-001 Nov 18, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Alpharma Us Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alpharma Us Pharms SERAX oxazepam CAPSULE;ORAL 015539-002 Approved Prior to Jan 1, 1982 4,620,974 ➤ Sign Up
Alpharma Us Pharms SERAX oxazepam CAPSULE;ORAL 015539-006 Approved Prior to Jan 1, 1982 4,620,974 ➤ Sign Up
Alpharma Us Pharms SERAX oxazepam CAPSULE;ORAL 015539-004 Approved Prior to Jan 1, 1982 4,620,974 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Citi
Fuji
US Department of Justice
Teva
Covington
Medtronic
Accenture
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.